ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Home parenteral nutrition

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10383648" target="_blank" >RIV/00216208:11110/18:10383648 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/18:10383648 RIV/00064203:_____/18:10383648 RIV/00064165:_____/18:10383648

Výsledek na webu

<a href="https://doi.org/10.1016/j.clnu.2018.06.954" target="_blank" >https://doi.org/10.1016/j.clnu.2018.06.954</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.clnu.2018.06.954" target="_blank" >10.1016/j.clnu.2018.06.954</a>

Jazyk výsledku

angličtina

Název v původním jazyce

ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Home parenteral nutrition

Popis výsledku v původním jazyce

Home parenteral nutrition (Home PN) is the best alternative to prolonged hospitalisation and the best option for improving the quality of life of children dependent on long-term PN. Furthermore, Home PN is associated with lower risks of complications such as catheter related blood stream infections (CRBSI) and overall cost. Therefore, Home PN should be considered for any child who is clinically stable and expected to remain dependent on PN for at least three more months. Over the last decade, Home PN has increased rapidly due to improvement in survival with better quality of care of surgical treatment, of neonatal care, of daily catheter care and also of the composition of PN. Reported prevalence varies across studies ranging from 9.6 children per million in the Netherlands to 13.7 children per million in the U.K. In this chapter, we will discuss indications, organisational aspects, requirements, follow-up, complications, quality of life and long-term outcome of Home PN.

Název v anglickém jazyce

ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Home parenteral nutrition

Popis výsledku anglicky

Home parenteral nutrition (Home PN) is the best alternative to prolonged hospitalisation and the best option for improving the quality of life of children dependent on long-term PN. Furthermore, Home PN is associated with lower risks of complications such as catheter related blood stream infections (CRBSI) and overall cost. Therefore, Home PN should be considered for any child who is clinically stable and expected to remain dependent on PN for at least three more months. Over the last decade, Home PN has increased rapidly due to improvement in survival with better quality of care of surgical treatment, of neonatal care, of daily catheter care and also of the composition of PN. Reported prevalence varies across studies ranging from 9.6 children per million in the Netherlands to 13.7 children per million in the U.K. In this chapter, we will discuss indications, organisational aspects, requirements, follow-up, complications, quality of life and long-term outcome of Home PN.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30209 - Paediatrics

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical Nutrition

ISSN

0261-5614

e-ISSN

—

Svazek periodika

37

Číslo periodika v rámci svazku

6, Part B

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

8

Strana od-do

2401-2408

Kód UT WoS článku

000454376500013

EID výsledku v databázi Scopus

2-s2.0-85051071288